Published in BMJ on March 09, 1991
Recurrent miscarriage. BMJ (1991) 0.80
Nuclear factor-kappa B1 is associated with gastric cancer in a Chinese population. Medicine (Baltimore) (2014) 0.79
Recurrent abortion. BMJ (1991) 0.77
'Miscarriage or abortion?' Understanding the medical language of pregnancy loss in Britain; a historical perspective. Med Humanit (2013) 0.75
SPONTANEOUS ABORTION RISKS IN MAN: DATA FROM REPRODUCTIVE HISTORIES COLLECTED IN A MEDICAL GENETICS UNIT. Am J Hum Genet (1964) 3.43
Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet (1990) 2.87
Influence of past reproductive performance on risk of spontaneous abortion. BMJ (1989) 2.44
Distribution of beta2 microglobulin and HLA in chorionic villi of human placentae. Nature (1976) 2.30
Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol (1985) 1.57
Retracted Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation. BMJ (1990) 1.53
Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol (1989) 1.42
Recurrent early miscarriage and polycystic ovaries. BMJ (1988) 1.11
Natural killer (NK) cell activity of first trimester human decidua. Cell Immunol (1989) 1.08
Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril (1988) 1.08
Trophoblast modulation of maternal allogeneic recognition. Proc Natl Acad Sci U S A (1979) 0.95
The endocrinology of conception. Baillieres Clin Endocrinol Metab (1990) 0.89
Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Reprod (1990) 0.88
Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome. Lancet (1990) 0.85
Trophoblast membrane infusion for unexplained recurrent miscarriage. Br J Obstet Gynaecol (1988) 0.85
Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord (2001) 5.97
A thermodynamic scale for the beta-sheet forming tendencies of the amino acids. Biochemistry (1994) 2.98
The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol (1996) 2.90
Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG (2008) 2.89
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J (1999) 2.71
An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod (1994) 2.38
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
Protein alchemy: changing beta-sheet into alpha-helix. Nat Struct Biol (1997) 2.23
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008) 2.06
The risks associated with pregnancy in women aged 35 years or older. Hum Reprod (2000) 2.06
Modular arrangement of functional domains along the sequence of an aminoacyl tRNA synthetase. Nature (1984) 2.04
Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95
Guidelines for protein design: the energetics of beta sheet side chain interactions. Science (1995) 1.88
Redesigning the hydrophobic core of a four-helix-bundle protein. Protein Sci (1994) 1.79
What makes a protein a protein? Hydrophobic core designs that specify stability and structural properties. Protein Sci (1996) 1.76
A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci U S A (2000) 1.70
An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold Des (1997) 1.57
Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London. BJOG (2001) 1.53
Dissecting RNA-protein interactions: RNA-RNA recognition by Rop. Cell (1995) 1.53
Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum Reprod (2002) 1.42
Glucose production by the human placenta in vivo. Placenta (1999) 1.42
Novel metal-binding proteins by design. Nat Struct Biol (1995) 1.41
Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Clin Sci (Lond) (2002) 1.38
Dispensable pieces of an aminoacyl tRNA synthetase which activate the catalytic site. Cell (1984) 1.28
Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod (1997) 1.28
Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol (2009) 1.27
Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol (2000) 1.27
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27
Dramatic structural and thermodynamic consequences of repacking a protein's hydrophobic core. Structure (2000) 1.27
Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod (1996) 1.26
Amino-acid substitutions in a surface turn modulate protein stability. Nat Struct Biol (1996) 1.22
Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol (2006) 1.20
Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol (2001) 1.19
Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. Eur J Radiol (2006) 1.18
A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod (2004) 1.16
Transmuting alpha helices and beta sheets. Fold Des (1997) 1.15
Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril (2000) 1.13
Sidechain interactions in parallel beta sheets: the energetics of cross-strand pairings. Structure (1999) 1.13
Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod (1999) 1.10
Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09
Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol (2003) 1.06
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod (2001) 1.05
Effect of alteration of the acetic acid synthesis pathway on the fermentation pattern of escherichia coli. Biotechnol Bioeng (1991) 1.05
Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol (2001) 1.05
The role of backbone conformational heat capacity in protein stability: temperature dependent dynamics of the B1 domain of Streptococcal protein G. Protein Sci (2000) 1.04
Recurrent miscarriage--an aspirin a day? Hum Reprod (2000) 1.04
Understanding the sequence determinants of conformational switching using protein design. Protein Sci (2000) 1.04
Polypeptide sequences essential for RNA recognition by an enzyme. Science (1987) 1.02
Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01
Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia (2009) 1.01
Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01
Aromatic rescue of glycine in beta sheets. Fold Des (1998) 0.99
Characterization of metal binding by a designed protein: single ligand substitutions at a tetrahedral Cys2His2 site. Biochemistry (1995) 0.99
Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod (2002) 0.98
Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis (2010) 0.97
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol (1999) 0.96
Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod (2006) 0.95
Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem (1999) 0.95
A further look at infection at the time of therapeutic abortion. Eur J Obstet Gynecol Reprod Biol (1990) 0.95
Reproducibility of three-dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol (2003) 0.95
Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod (2000) 0.95
A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod (2003) 0.95
A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem (1998) 0.94
High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod (1995) 0.94
Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod (1995) 0.92
Redesigning the topology of a four-helix-bundle protein: monomeric Rop. Biochemistry (1995) 0.92
G20210A prothrombin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost (2001) 0.92
Polycystic ovaries and recurrent miscarriage--a reappraisal. Hum Reprod (2000) 0.92
Using loop length variants to dissect the folding pathway of a four-helix-bundle protein. J Mol Biol (1999) 0.91
Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol (2005) 0.91
Determination of eleven coccidiostats in animal feed by liquid chromatography-tandem mass spectrometry at cross contamination levels. Anal Chim Acta (2010) 0.90
ColE1-compatible vectors for high-level expression of cloned DNAs from the T7 promoter. Gene (1994) 0.90
Is antipaternal cytotoxic antibody a valid marker in the management of recurrent abortion? Lancet (1987) 0.90
Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod (2003) 0.89
Speeding up protein folding: mutations that increase the rate at which Rop folds and unfolds by over four orders of magnitude. Fold Des (1997) 0.89
Absence of scaling for the intermediate scattering function of a hard-sphere suspension: static and dynamic x-ray scattering from concentrated polystyrene latex spheres. Phys Rev Lett (2000) 0.89
Psychiatric morbidity among patients with recurrent miscarriage. J Psychosom Obstet Gynaecol (2002) 0.89
Granulomatous orchitis. Br J Clin Pract (1983) 0.88
Anti-beta 2 glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol (2001) 0.88
Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids. Hum Reprod (2002) 0.87
Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod (2002) 0.87
Two mutations in the dispensable part of alanine tRNA synthetase which affect the catalytic activity. J Biol Chem (1985) 0.87
The de novo design of a rubredoxin-like Fe site. Protein Sci (1998) 0.87
Histological chorioamnionitis in relation to clinical presentation at 14-40 weeks of gestation. J Obstet Gynaecol (2001) 0.87
Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study. Hum Reprod (1999) 0.86
Proteomics of Mycoplasma genitalium: identification and characterization of unannotated and atypical proteins in a small model genome. Nucleic Acids Res (2000) 0.86
The design of a four-helix bundle protein. Cold Spring Harb Symp Quant Biol (1987) 0.86
Modulating protein folding rates in vivo and in vitro by side-chain interactions between the parallel beta strands of green fluorescent protein. J Biol Chem (2000) 0.84
Glucose production in the human placenta. Placenta (2006) 0.84
The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss. Br J Haematol (1999) 0.84
Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J Clin Endocrinol Metab (2002) 0.84
Secondary ligands enhance affinity at a designed metal-binding site. Chem Biol (1999) 0.83
Increased thrombin generation in women with recurrent miscarriage. Lancet (1998) 0.83
A bacterial and silkworm aminoacyl-tRNA synthetase have a common epitope which maps to the catalytic domain of each. J Biol Chem (1986) 0.83
Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ (1996) 0.83
Comparison of protein backbone entropy and beta-sheet stability: NMR-derived dynamics of protein G B1 domain mutants. J Am Chem Soc (2001) 0.82
Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG (2002) 0.81
Rapid confirmatory method for the determination of sixteen synthetic growth promoters and bisphenol A in bovine milk using dispersive solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.81